Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2430053
Max Phase: Preclinical
Molecular Formula: C24H18O6
Molecular Weight: 402.40
Molecule Type: Small molecule
Associated Items:
ID: ALA2430053
Max Phase: Preclinical
Molecular Formula: C24H18O6
Molecular Weight: 402.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(CC(=O)c1cc(C(=O)CC(=O)c2ccccc2)c(O)cc1O)c1ccccc1
Standard InChI: InChI=1S/C24H18O6/c25-19(15-7-3-1-4-8-15)12-21(27)17-11-18(24(30)14-23(17)29)22(28)13-20(26)16-9-5-2-6-10-16/h1-11,14,29-30H,12-13H2
Standard InChI Key: ACULOALQGPYYBW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 402.40 | Molecular Weight (Monoisotopic): 402.1103 | AlogP: 4.01 | #Rotatable Bonds: 8 |
Polar Surface Area: 108.74 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.12 | CX Basic pKa: | CX LogP: 5.07 | CX LogD: 4.59 |
Aromatic Rings: 3 | Heavy Atoms: 30 | QED Weighted: 0.44 | Np Likeness Score: 0.13 |
1. Juneja H, Panchbhai D, Sheikh J, Ingle V, Hadda TB. (2013) Synthesis, antibacterial screening, and POM analyses of novel bis-isoxazolyl/pyrazolyl-1,3-diols, [10.1007/s00044-013-0755-5] |
Source(1):